Verified peer comparison
Bristol-Myers Squibb vs AstraZeneca Financial Comparison
Direct answer
Bristol-Myers Squibb and AstraZeneca are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Bristol-Myers Squibb email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Bristol-Myers Squibb Revenue
- 48,195,000,000 USD
- AstraZeneca Revenue
- 58,739,000,000 USD
- Bristol-Myers Squibb Operating income
- 13,724,000,000 USD
- AstraZeneca Operating income
- 13,743,000,000 USD